ARTICLE
|
doi:10.20944/preprints202205.0142.v1
Subject:
Medicine And Pharmacology,
Oncology And Oncogenics
Keywords:
glioblastoma; immunotherapy; radiotherapy; brain cancers; radioimmunotherapy; immune checkpoint inhibitors; temozolomide; durvalumab; immunoradiotherapy.
Online: 10 May 2022 (13:22:16 CEST)